Skip to main content
SpringerLink
Log in

Evidence that high dose Cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor

  • Journal Club
  • Recently published papers, considered to be of high relevance, commented upon by invited discussants
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Clore J.N., Estep H., Ross-Clunis H., Watlington C.O. Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486. J. Clin. Endocrinol. Metab. 67: 824, 1988.

    Article  PubMed  CAS  Google Scholar 

  2. Whitworth J.A., Gordon D., Andrews J., Scoggins B. The hypertensive effect of synthetic glucocorticoids in man. Role of sodium and volume. J. Hypertens. 7: 537, 1989.

    Article  PubMed  CAS  Google Scholar 

  3. Connell J.M.C., Whitworth J.A., Davies D.L., Richards A.M., Fraser R. Haemodynamic, hormonal and renal effects of ACTH in sodium restricted man. J. Hypertens. 6: 17, 1988.

    Article  PubMed  CAS  Google Scholar 

  4. Ulick S., Levine L.S., Gunczler P., Zanconata G., Ramirez L.C., Rauh W., Rosier A., Bradlow H.L., New M.I. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocrinol. Metab. 49: 757, 1979.

    Article  PubMed  CAS  Google Scholar 

  5. Stewart P.M., Corrie J.E.T., Schakleton C.H.L., Edwards C.R.W. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J. Clin. Invest. 82: 340, 1988.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  6. Speiser P.W., Riddick L.M., Martin K., New M.I. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess. Metab. 42: 843, 1993.

    Article  CAS  Google Scholar 

  7. Oberfield S.E., Levine L.S., Carey R.M., Greig F, Ulick S., New M.I. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 56: 332, 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Montrella-Waybill M., Clore J.N., Schoolwerth A.C., Watlington C.O. Evidence that high dose cortisol-induced Na retention in man is not mediated by the mineralocorticoid receptor. J. Clin. Endocrinol. Metab. 72: 1060, 1991.

    Article  PubMed  CAS  Google Scholar 

  9. Kassirer J.P., London A.M., Goldman D.M., Schwartz W.B. On the pathogenesis of metabolic alkalosis in hyperaldosteronsism. Am. J. Med. 49: 306, 1970.

    Article  PubMed  CAS  Google Scholar 

  10. New M.I., Nemery R.L., Chow D.M., Kaufman E.D., Stoner E., Zerah M., Crawford C., Speiser P.W. Low renin hypertension of childhood. In: Mantero F. (Ed.), The adrenal and hypertension: from cloning to clinic. Serono Symposium. Raven Press, 1989: 321. vol 57).

  11. Edwards C.R.W., Stewart P.M. Defective cortisol: cortisone shuttle: Novel mechanism for the genesis of hypertension. In: Mantero F. (Ed.), The adrenal and hypertension: from cloning to clinic. Serono Symposium. Raven Press, 1989: 57: 345

  12. Morgan T.O. The use of diuretic drugs and aldosterone antagonists in hypertension. In: Doyle A.E. (Ed.), Handbook of Hypertension; vol 5: Clinical Pharmacology of Antihypertensive Drugs. Elsevier Science, 1984, p. 67.

  13. Scoggins B.A., Coghlan J.P., Denton D.A., Mills E.H., Nelson M.A., Spence C.D., J.A.W. How do adrenocortical steroid hormones produce hypertension? Clin. Exp. Hypertens. 6: 315, 1984.

    Article  CAS  Google Scholar 

  14. Whitworth J.A., Scoggins B.A. A ‘hypertensinogenic’ class of steroid hormone activity in man? Clin. Exp. Pharmacol. Physiol. 17: 163, 1990.

    Article  PubMed  CAS  Google Scholar 

  15. Grunfeld J-P., Eloy L., Moura A-M., Ganeval D., Ramos-Frendo B., Worcel M. Effects of antiglucocorticoids on glucocorticoid hypertension in the rat. Hypertension 7: 292, 1985.

    Article  PubMed  CAS  Google Scholar 

  16. Grunfeld J-P., Eloy L. Glucocorticoid antagonists as probes to study the vascular effects of glucocorticoids. Kidney Int. 34(Suppl 26): S24, 1988.

    Google Scholar 

  17. Yagil Y., Koreen R., Krakoff L.R. Role of mineralocorticoids and glucocorticoids in blood pressure regulation in normotensive rats. Am. J. Physiol. 251: H1354, 1986.

    PubMed  CAS  Google Scholar 

  18. Pirpiris M., Yeung S., Dewar E., Jennings G.L., Whitworth J.A. Hydrocortisone induced hypertension in men. The role of cardiac output. Am. J. Hypertens. 6: 287, 1993.

    Article  PubMed  CAS  Google Scholar 

  19. Connell J.M.C., Whitworth J.A., Davies D.L., Lever A.F., Richards A.M., Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J. Hypertens. 5: 425, 1987.

    Article  PubMed  CAS  Google Scholar 

  20. Huang M., Hester R.L., Coleman T.G., Smith M.J., Guyton A.C. Development of hypertension in animals with reduced total peripheral vascular resistance. Hypertension 20: 828, 1992.

    Article  PubMed  CAS  Google Scholar 

  21. Whitworth J.A., Connell J.M.C., Lever A.F., Fraser R. Pressor responsiveness in steroid-induced hypertension in man. Clin. Exp. Pharmacol. Physiol. 13: 353, 1986.

    Article  PubMed  CAS  Google Scholar 

  22. Sudhir K., Jennings G.L., Esler M.D., Korner P.I., Blombery P.A., Lambert G.W., Scoggins B., Whitworth J.A. Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension 13: 416, 1989.

    Article  PubMed  CAS  Google Scholar 

  23. Pirpiris M., Sudhir K., Yeung S., Jennings G.L., Whitworth J.A. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 19: 567, 1992.

    Article  PubMed  CAS  Google Scholar 

  24. Axelrod L. Inhibition of prostacyclin production mediates a permissive effect of glucocorticoids on vascular tone. Lancet i: 904, 1983.

    Article  Google Scholar 

  25. Whitworth J.A., Connell J.M.C., Gordon D., Scoggins B.A. Effects of indomethacin on steroid induced changes in pressor responsiveness in man. Clin. Exp. Pharmacol. Physiol. 15: 305, 1988.

    Article  PubMed  CAS  Google Scholar 

  26. Radomski M.W., Palmer R.M.J., Moncada S. Glucocortiocoids inhibit the expression of an inducible but not constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. 87: 10043, 1990.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  27. Nakamura K., Gerald M., Thoenen H. Experimental hypertension in the rat: reciprocal changes in norepinephrine turnover in heart and brain. Arch. Pharmacol. 268: 125, 1971.

    Article  CAS  Google Scholar 

  28. De Champlain J., Van Ameringan M.R. Regulation of blood pressure by sympathetic nerve fibres in adrenal medulla in normotensive and hypertensive rats. Circ. Res. 31: 617, 1972.

    Article  PubMed  Google Scholar 

  29. Whitworth J.A., Williamson P.M., Brown M.A., Morris M.J. Neuropeptide Y in cortisol induced hypertension in man. Clin. Exp. Pharmacol. Physiol. 21: 435, 1994.

    Article  PubMed  CAS  Google Scholar 

  30. Pirpiris M., Cox H., Esler M., J.ennings J.L., Whitworth J.A. Mineralocorticoid induced hypertension and noradrenaline spillover in man. Clin. Exp. Hypertens. 16: 147, 1994.

    Article  PubMed  CAS  Google Scholar 

  31. Tam S.H., Kelly J.J., Williamson P.M., Whitworth J.A. Reflex sympathetic function in cortisol induced hypertension in humans. Manuscript in preparation 1995.

  32. Philipp T., Distler A., Cordes U., Wolff H.P. Plasma noradrenaline and pressor action of exogenous noradrenaline in normotensive subjects and patients with essential hypertension. Clin. Sci. Mol. Med. 55: 61s, 1978.

  33. Philipp T., Distler A., Cordes U. Sympathetic nervous system and blood pressure control in essential hypertension. Lancet ii: 959, 1978.

    Article  Google Scholar 

  34. De Fronzo R.A. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 21: 165, 1981.

    Google Scholar 

  35. Whitworth J.A., Williamson P.M., Brown M.A., Colman P. Hyperinsulinaemia is not a cause of cortisol induced-hypertension. Am. J. Hypertens. 7: 562, 1994.

    PubMed  CAS  Google Scholar 

  36. Soro A., Ingram M.C., Tonolo G., Glorioso N., Fraser R. Evidence of coexisiting changes in 11ß-hydroxysteroid dehydrogenase and 5ß-reductase activity in subjects with untreated essential hypertension. Hypertension 25: 67, 1995.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Endocrinology and Nephrology, Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, 23298-0145, USA

    Montrella-Waybill M., Clore J. N., Schoolwerth A. C. & Watlington C. O.

  2. Department of Medicine. The St. George Hospital, University of New South Wales, Sidney, NSW, 2217, Australia

    J. A. Whitworth & J. J. Kelly

Authors
  1. Montrella-Waybill M.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clore J. N.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Schoolwerth A. C.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Watlington C. O.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. A. Whitworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. J. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montrella-Waybill, M., Clore, J.N., Schoolwerth, A.C. et al. Evidence that high dose Cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor. J Endocrinol Invest 18, 586–591 (1995). https://doi.org/10.1007/BF03349774

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349774

Keywords

Search

Navigation